Market Tracker weekly round-up—20 December 2018

Market Tracker weekly round-up—20 December 2018

Weekly round-up of the latest corporate announcements, including a secondary offer by Summit Therapeutics plc, a possible reverse takeover by Fandango Holdings plc, capital reorganisations by ASA International Group plc and Intercontinental Group plc, returns of value by Intercontinental Group plc and XLMedia plc, joint ventures between GlaxoSmithKline plc and Pfizer Inc. and between Panthera Resources plc and Galactic Gold Mines Private Limited, a delisting of Akers Biosciences Inc., a related party transaction by GlaxoSmithKline plc, and 4 AGM notices.

This weekly round-up covers all deals announced within our statement of scope from 12 noon on Friday 14 December 2018 until 12 noon on Thursday 20 December 2018. Any deals announced after this time will be included in our daily round-up when we resume service on 3 January 2019.

All transactions covered in this update are available on the Market Tracker deal analysis tool containing over 4,000 public company deal summaries.

New deals (and AGMs) announced:


Announcement dateCompanyIndustry sectorKey information
20 December 2018Renew Holdings plcProfessional ServicesRenew Holdings has announced that its 2019 AGM will be held on 30 January 2019.
18 December 2018UDG Healthcare plcHealthcareUDG Healthcare has announced that its 2019 AGM will be held on 29 January 2019.
17 December 2018Mitchells & Butlers plcTravel, Hospitality, Leisure & TourismMitchells & Butlers has announced that its 2019 AGM will be held on 22 January 2019.

Subscription Form

Already a subscriber? Login
RELX (UK) Limited, trading as LexisNexis, and our LexisNexis Legal & Professional group companies will contact you to confirm your email address. You can manage your communication preferences via our Preference Centre. You can learn more about how we handle your personal data and your rights by reviewing our  Privacy Policy.

Related Articles:
Latest Articles:

Access this article and thousands of others like it free by subscribing to our blog.

Read full article

Already a subscriber? Login